Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysis.
Future Oncol
; 20(31): 2303-2305, 2024.
Article
de En
| MEDLINE
| ID: mdl-39129712
ABSTRACT
Artificial intelligence (AI) has rapidly advanced in the past years, particularly in medicine for improved diagnostics. In clinical cytogenetics, AI is becoming crucial for analyzing chromosomal abnormalities and improving precision. However, existing software lack learning capabilities from experienced users. AI integration extends to genomic data analysis, personalized medicine and research, but ethical concerns arise. In this article, we discuss the challenges of the full automation in cytogenetic test interpretation and focus on its importance and benefits.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Intelligence artificielle
/
Analyse cytogénétique
/
Tumeurs
Limites:
Humans
Langue:
En
Journal:
Future Oncol
Année:
2024
Type de document:
Article
Pays d'affiliation:
Liban
Pays de publication:
Royaume-Uni